Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Expiration dates on tubes

This article was originally published in The Tan Sheet

Executive Summary

Expiration dates on tubes: Expiration dating placed on the crimp of a dispensing tube "is an acceptable way to comply" with current regs, FDA tells Bob Nakutin, Westport, Wash., in an April 22 response to his citizen petition. The petition requests that the expiration date be placed in a "more visible location" -- consumers often roll up tubes, rendering the date invisible -- and that it be "made easily legible" through the use of contrasting colors. FDA responded that "no known problems have been associated with such information appearing on the crimp of the dispensing tube," and it has "not encountered any [dates] that are unreadable due to lack of color contrast"...

Expiration dates on tubes: Expiration dating placed on the crimp of a dispensing tube "is an acceptable way to comply" with current regs, FDA tells Bob Nakutin, Westport, Wash., in an April 22 response to his citizen petition. The petition requests that the expiration date be placed in a "more visible location" -- consumers often roll up tubes, rendering the date invisible -- and that it be "made easily legible" through the use of contrasting colors. FDA responded that "no known problems have been associated with such information appearing on the crimp of the dispensing tube," and it has "not encountered any [dates] that are unreadable due to lack of color contrast"....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087058

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel